Gastroenterologia
Breve revisão | Diagnóstico e tratamento da gastroparesia.
13 Dez, 2022 | 15:06hDiagnosis and Management of Gastroparesis – The American Journal of Gastroenterology
Conteúdos relacionados:
Worldwide prevalence and burden of gastroparesis-like symptoms.
ACG Clinical Guideline: Gastroparesis – The American Journal of Gastroenterology
Resumo de diretriz | Avaliação e tratamento da doença do refluxo gastroesofágico.
6 Dez, 2022 | 12:04hDiretriz original: ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease – American Journal of Gastroenterology
Diretrizes relacionadas:
ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease.
SAGES guidelines for the surgical treatment of gastroesophageal reflux.
Guideline on Screening for Esophageal Adenocarcinoma in Patients with Chronic GERD
NICE Guideline: Gastro-esophageal Reflux Disease and Dyspepsia in Adults
NICE Guideline: Gastroesophageal Reflux Disease in Children and Young People
Revisão | Tratamento da lesão renal aguda em pacientes com cirrose.
6 Dez, 2022 | 11:57hManagement of AKI in Patients with Cirrhosis – Current Treatment Options in Gastroenterology
Conteúdo relacionado: AGA Clinical Practice Update on the Evaluation and Management of Acute Kidney Injury in Patients With Cirrhosis: Expert Review – Clinical Gastroenterology and Hepatology
Revisão | Dissinergia abdominofrênica.
28 Nov, 2022 | 14:43hAbdominophrenic Dyssynergia: A Narrative Review – The American Journal of Gastroenterology
Comentário do autor no Twitter
Very excited to share our review on abdomino-phrenic dyssynergia!
🎈This physiology is an important contributor to bloating and distension in disorders of gut-brain interaction! #MedTwitter #GITwitter #DGBI #FGID #IBS @AmJGastro https://t.co/nylhtB5uPq pic.twitter.com/7vsVkHatbu
— John Damianos, M.D. (@john_damianosMD) October 5, 2022
Revisão | Medidas de saúde pública e prevenção de doenças hepáticas associadas ao álcool.
28 Nov, 2022 | 14:42h
Comentário de um dos autores no Twitter
Public Health Measures and Prevention of Alcohol-Associated Liver Disease @JCEH_Hepatology @LuisAntonioDiaz @FcoIdalsoaga @CokeArnold1 #LiverTwitter https://t.co/8pVLg5Kffp pic.twitter.com/OCrIYgVhJa
— Juan Pablo (JP) Arab, MD (@juanpabloarab) June 28, 2022
Revisão | Retirada de inibidores da bomba de prótons.
28 Nov, 2022 | 14:31hDeprescribing proton pump inhibitors – Australian Journal of General Practice
Benefícios de 15 anos do rastreamento por sigmoidoscopia na incidência e na mortalidade de câncer colorretal: análise agrupada de estudos randomizados.
17 Out, 2022 | 13:34h15-Year Benefits of Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality: A Pooled Analysis of Randomized Trials – Annals of Internal Medicine (link para o resumo – $ para o texto completo)
Comunicado de imprensa: One sigmoidoscopy significantly reduces long-term CRC incidence in both men and women – American College of Physicians
Conteúdos relacionados:
RCT | Effect of colonoscopy screening on risks of colorectal cancer and related death.
ACP Guideline: Screening for Colorectal Cancer in Asymptomatic Average-Risk Adults
Current and future colorectal cancer screening strategies – Nature Reviews Gastroenterology & Hepatology (se o acesso a este link for pago, tente este em PMC)
USPSTF Statement: Start colorectal cancer screening at 45 years for most patients.
ACG Clinical Guidelines: Start colorectal cancer screening at 45
Comentário no Twitter
A pooled analysis evaluating 15-yr effect of sigmoidoscopies found that receiving 1 #sigmoidoscopy significantly reduces long-term incidence of CRC in men and women: https://t.co/QXj5VRMHeo pic.twitter.com/s82sOJmBzr
— Annals of Int Med (@AnnalsofIM) October 11, 2022
Recomendações de consenso | Como minimizar o risco de transmissão do vírus da varíola dos macacos durante o transplante de microbiota fecal.
17 Out, 2022 | 13:04h
Riscos e benefícios associados à continuação de anti-TNF após 24 semanas de gestação na doença inflamatória intestinal.
17 Out, 2022 | 13:02hBenefits and Risks Associated With Continuation of Anti–Tumor Necrosis Factor After 24 Weeks of Pregnancy in Women With Inflammatory Bowel Disease – Annals of Internal Medicine (link para o resumo – $ para o texto completo)
Comunicado de imprensa: Anti-TNF continuation after 24 weeks of pregnancy beneficial to persons with IBD, does not affect neonatal outcomes – American College of Physicians
Comentário: Continuation of Anti-TNF for IBD After 24 Weeks of Pregnancy Beneficial – HealthDay
Comentário no Twitter
10 year trial found continuation of #AntiTNF treatment after 24 weeks of pregnancy appears beneficial for #IBD activity and prematurity, not affecting neonatal outcomes and serious infections in the offspring. @EPIPHARE https://t.co/YuytSQqDsE pic.twitter.com/CRGN80K93A
— Annals of Int Med (@AnnalsofIM) September 27, 2022
Estudo randomizado | Efeito do rastreamento com colonoscopia sobre os riscos de câncer colorretal e morte relacionada.
17 Out, 2022 | 12:59hEffect of Colonoscopy Screening on Risks of Colorectal Cancer and Related Death – New England Journal of Medicine (link para o resumo – $ para o texto completo)
Comentários:
In gold-standard trial, invitation to colonoscopy reduced cancer incidence but not death – STAT
New study examines the effectiveness of colonoscopies – CNN